Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids

被引:73
作者
Berton, A
Rigot, V
Huet, E
Decarme, M
Eeckhout, Y
Patthy, L
Godeau, G
Hornebeck, W
Bellon, G
Emonard, H
机构
[1] Fac Med, CNRS, FRE 2260, IFR Biomol 53, F-51100 Reims, France
[2] Inst Cellular Pathol, Cell Biol Unit, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, B-1200 Brussels, Belgium
[4] Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1518 Budapest, Hungary
[5] Univ Paris 05, Fac Odontol, Biochem Lab, F-92120 Montrouge, France
关键词
D O I
10.1074/jbc.M011664200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The matrix metalloproteinases gelatinase A (MMP-2) and gelatinase B (MMP-9) are implicated in the physiological and pathological breakdown of several extracellular matrix proteins. In the present study, we show that long-chain fatty acids (e.g. oleic acid, elaidic acid, and cis- and trans-parinaric acids) inhibit gelatinase A as well as gelatinase B with K-i values in the micromolar range but had only weak inhibitory effect on collagenase-1 (MMP-1), as assessed using synthetic or natural substrates, The inhibition of gelatinases depended on fatty acid chain length (with C18 > C16, C14, and C10), and the presence of unsaturations increased their inhibitory capacity on both types of gelatinase, Ex vivo experiments on human shin tissue sections have shown that micromolar concentrations of a long-chain unsaturated fatty acid (elaidic acid) protect collagen and elastin fibers against degradation by gelatinases A and B, respectively. In order to understand why gelatinases are more susceptible than collagenase-1 to inhibition by long-chain fatty acids, the possible role of the fibronectin-like domain (a domain unique to gelatinases) in binding inhibitory fatty acids was investigated. Affinity and kinetic studies with a recombinant fibronectin-like domain of gelatinase A and with a recombinant mutant of gelatinase A from which this domain had been deleted pointed to an interaction of long-chain fatty acids with the fibronectin-like domain of the protease, Surface plasmon resonance studies on the interaction of long-chain fatty acids with the three individual type II modules of the fibronectin-like domain of gelatinase A revealed that the first type II module is primarily responsible for binding these compounds.
引用
收藏
页码:20458 / 20465
页数:8
相关论文
共 52 条
[11]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[12]   The second type II module from human matrix metalloproteinase 2:: structure, function and dynamics [J].
Briknarová, K ;
Grishaev, A ;
Bányai, L ;
Tordai, H ;
Patthy, L ;
Llinás, M .
STRUCTURE, 1999, 7 (10) :1235-1245
[13]   MATRILYSIN-INHIBITOR COMPLEXES - COMMON THEMES AMONG METALLOPROTEASES [J].
BROWNER, MF ;
SMITH, WW ;
CASTELHANO, AL .
BIOCHEMISTRY, 1995, 34 (20) :6602-6610
[14]   Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system [J].
Carmeliet, P ;
Collen, D .
THROMBOSIS RESEARCH, 1998, 91 (06) :255-285
[15]  
COLLIER IE, 1992, J BIOL CHEM, V267, P6776
[16]  
COLLIER IE, 1988, J BIOL CHEM, V263, P6579
[17]   Matrix metalloproteinases and the development of cancer [J].
Coussens, LM ;
Werb, Z .
CHEMISTRY & BIOLOGY, 1996, 3 (11) :895-904
[18]   n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation [J].
Curtis, CL ;
Hughes, CE ;
Flannery, CR ;
Little, CB ;
Harwood, JL ;
Caterson, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) :721-724
[19]   EVIDENCE FOR METALLOPROTEINASE AND METALLOPROTEINASE INHIBITOR IMBALANCE IN HUMAN OSTEOARTHRITIC CARTILAGE [J].
DEAN, DD ;
MARTELPELLETIER, J ;
PELLETIER, JP ;
HOWELL, DS ;
WOESSNER, JF .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (02) :678-685
[20]  
Dobrin P B, 1994, Cardiovasc Surg, V2, P484